- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Palatin Technologies Inc (PTNT)
Palatin Technologies Inc stock price live, this page displays OTC PTNT stock exchange data. View the PTNT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Palatin Technologies Inc real time stock price chart below.
What Is the Palatin Technologies Inc Stock Price Today?
The Palatin Technologies Inc stock price today is 0.1655.
What Is the Stock Symbol for Palatin Technologies Inc?
The stock symbol for Palatin Technologies Inc is ""PTNT.""
What Stock Exchange Does Palatin Technologies Inc Trade On?
Palatin Technologies Inc is listed and trades on the OTC Markets stock exchange.
Is Palatin Technologies Inc a Good Stock to Buy?
Determining whether Palatin Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PTNT quote. (ISIN: US6960775020)
What Is the Palatin Technologies Inc Stock Price Today?
The Palatin Technologies Inc stock price today is 0.1655.
What Is the Stock Symbol for Palatin Technologies Inc?
The stock symbol for Palatin Technologies Inc is ""PTNT.""
What Stock Exchange Does Palatin Technologies Inc Trade On?
Palatin Technologies Inc is listed and trades on the OTC Markets stock exchange.
Is Palatin Technologies Inc a Good Stock to Buy?
Determining whether Palatin Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PTNT quote. (ISIN: US6960775020)
0.1655
-0.0155(-8.56%)
Closed·
Fair Value
An estimate of a Palatin's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1620
0.1910
52 wk Range
0.0350
1.7200
PTNT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
PTNT is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Palatin's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.16200.1910
52 wk Range
0.03501.7200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PTNT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Palatin's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Palatin Technologies Inc Company Profile
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company’s lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.
Palatin Technologies Inc Earnings Call Summary for Q3/2025
- Q3 FY2025 net loss narrowed to $4.8M from $8.4M YoY; EPS of -$0.18 beat -$0.46 forecast
- No product sales due to Vyleesi rights sale; cash and equivalents at $2.5M, with $3.5M received post-quarter
- FDA granted orphan drug status to PL7737; NDA submission planned for Q1 2026, pending financing
- Delisted from NYSE American, now on OTC Pink; seeking new funding and business development opportunities
- Executives highlight early stage of obesity treatment innovation; partnerships for ulcerative colitis and dry eye programs expected H2 2025
Last Updated: 14/05/2025, 16:38
Read Full TranscriptCompare PTNT to Peers and Sector
Metrics to compare | PTNT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPTNTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −3.8x | −0.5x | |
PEG Ratio | −0.01 | −0.16 | 0.00 | |
Price/Book | −1.2x | 2.1x | 2.6x | |
Price / LTM Sales | 22.6x | 10.3x | 3.3x | |
Upside (Analyst Target) | - | 110.9% | 43.5% | |
Fair Value Upside | Unlock | 11.9% | 6.3% | Unlock |
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-0.18 / -0.46
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Palatin Trade On?
Palatin is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Palatin?
The stock symbol for Palatin is "PTNT."
What Is the Palatin Market Cap?
As of today, Palatin market cap is 7.67M.
What Is Palatin's Earnings Per Share (TTM)?
The Palatin EPS (TTM) is -1.12.
When Is the Next Palatin Earnings Date?
Palatin will release its next earnings report on 06 Oct 2025.
From a Technical Analysis Perspective, Is PTNT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Palatin Stock Split?
Palatin has split 4 times.
How Many Employees Does Palatin Have?
Palatin has 30 employees.
What is the current trading status of Palatin (PTNT)?
As of 05 Aug 2025, Palatin (PTNT) is trading at a price of 0.17, with a previous close of 0.17. The stock has fluctuated within a day range of 0.16 to 0.19, while its 52-week range spans from 0.04 to 1.72.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.